Home > Healthcare > Pharmaceuticals > Finished Drug Form > Topical Antibiotics Market

Topical Antibiotics Market Size

  • Report ID: GMI8570
  • Published Date: Mar 2024
  • Report Format: PDF

Topical Antibiotics Market Size

Topical Antibiotics Market size was valued at USD 6.4 billion in 2023 and is expected to grow at a CAGR of 5.4% between 2024 and 2032. The market is experiencing significant growth due to the increasing prevalence of bacterial infections and skin conditions globally.


According to the World Health Organization (WHO), approximately 1.8 billion individuals are estimated to be affected by various skin conditions at any given time. Thus, the rise in cases of skin infections, such as bacterial dermatitis, acne, and surgical site infections has increased market demand for topical antibiotics. Moreover, advancements in formulation technologies and the introduction of novel delivery systems enhance the efficacy and patient compliance of topical antibiotics, contributing to sustained market growth amidst evolving healthcare needs.

Topical antibiotics are pharmaceutical formulations designed for external application to the skin or mucous membranes, primarily to combat bacterial infections and prevent their spread. These medications contain antibiotics that inhibit bacterial growth or kill bacteria at the site of infection.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Topical antibiotics industry size was USD 6.4 billion in 2023 and is expected to reach USD 10.4 billion by 2032, due to the increasing prevalence of bacterial infections and skin conditions globally.

The tetracycline drug class segment is set to experience 5.2% growth rate from 2024 to 2032, driven by their broad spectrum of activity against various bacterial infections, widespread availability, and established efficacy in treating a diverse range of conditions.

North America topical antibiotics industry is projected to reach USD 4.4 billion by 2032, led by advanced healthcare infrastructure, high healthcare expenditure, and a robust regulatory framework facilitating drug approvals.

Some of the prominent topical antibiotic firms are Almirall S.A., Bausch Health Companies Inc., Bayer AG, GlaxoSmithKline plc, Johnson & Johnson Consumer Inc., and Lupin, among others.

Topical Antibiotics Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 292
  • Countries covered: 19
  • Pages: 160
 Download Free Sample